CRXT insider filings
Clarus Therapeutics Holdings, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-06-09. Screen CRXT transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CRXT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Clarus Therapeutics Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-06-09 | 4 | Amory John Kenneth — Director | Grant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Murphy Kimberly M — Director | Grant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Hernandez Joseph — Director | Grant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Cermak Elizabeth — Director | Grant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | PRYGOCKI MARK A SR — Director | Grant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0 | EDGAR |
| 2022-04-27 | 4 | Hernandez Joseph — Director | Other (J): 65,000 @ $0 · Other (J): 1,237,500 @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1 | EDGAR |
| 2022-04-25 | 4/A | THOMAS MCNERNEY & PARTNERS LP — 10% owner TMP ASSOCIATES LP — 10% owner TMP Nominee, LLC — 10% owner Thomas, McNerney & Partners, LLC — 10% owner Thomas, McNerney & Partners II L.P. — 10% owner TMP Associates II LP — 10% owner TMP Nominee II, LLC — 10% owner Thomas, McNerney & Partners II, LLC — 10% owner THOMAS JAMES E — 10% owner | Sale (S): 1,663,126 @ $2.53 · Sale (S): 2,061,685 @ $2.53 · Sale (S): 5,722 @ $2.53 · Sale (S): 13,630 @ $2.53 · Sale (S): 1,164 @ $2.53 · Sale (S): 7,585 @ $2.53 | EDGAR |
| 2022-04-21 | 4 | THOMAS MCNERNEY & PARTNERS LP — 10% owner TMP ASSOCIATES LP — 10% owner TMP Nominee, LLC — 10% owner Thomas, McNerney & Partners, LLC — 10% owner Thomas, McNerney & Partners II L.P. — 10% owner TMP Associates II LP — 10% owner TMP Nominee II, LLC — 10% owner Thomas, McNerney & Partners II, LLC — 10% owner THOMAS JAMES E — 10% owner | Sale (S): 1,663,126 @ $2.53 · Sale (S): 2,061,685 @ $2.53 · Sale (S): 5,722 @ $2.53 · Sale (S): 13,630 @ $2.53 · Sale (S): 1,164 @ $2.53 · Sale (S): 7,585 @ $2.53 | EDGAR |
| 2021-12-14 | 4 | Jaeger Frank — Chief Commercial Officer | Grant/award (A): 29,000 @ $0 · Grant/award (A): 72,500 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Amory John Kenneth — Director | Grant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Murphy Kimberly M — Director | Grant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Hernandez Joseph — Director | Grant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Dudley Robert E. — Chief Executive Officer, Director | Grant/award (A): 135,000 @ $0 · Grant/award (A): 337,500 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Bourne Steven A. — Chief Administrative Officer | Grant/award (A): 29,000 @ $0 · Grant/award (A): 72,500 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Cermak Elizabeth — Director | Grant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | PETERSON RICHARD D — Chief Financial Officer | Grant/award (A): 55,800 @ $0 · Grant/award (A): 139,500 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | PRYGOCKI MARK A SR — Director | Grant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0 | EDGAR |
| 2021-10-04 | 4 | H.I.G. Ventures - Clarus, LLC — 10% owner H.I.G. Bio-Clarus II, L.P. — 10% owner H.I.G. Bio-Clarus I, L.P. — 10% owner H.I.G.-GPII, Inc. — 10% owner TAMER ANTHONY — 10% owner MNAYMNEH SAMI — 10% owner | Grant/award (A): 490,531 @ $0 · Grant/award (A): 2,731,094 @ $0 · Grant/award (A): 2,470,756 @ $0 | EDGAR |
| 2021-09-23 | 4/A | Hernandez Joseph — Director Blue Water Sponsor LLC | Option exercise (M): 1,437,500 @ $0 · Other (J): 135,000 @ $0 · Option exercise (M): 1,437,500 (derivative) @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1 | EDGAR |
| 2021-09-21 | 4 | FFI FUND LTD — 10% owner FYI Ltd — 10% owner Olifant Fund, Ltd. — 10% owner Bracebridge Capital, LLC — 10% owner | Sale (S): 127,360 @ $9.20 | EDGAR |
| 2021-09-13 | 4 | Zisson Alex — Director, 10% owner | Grant/award (A): 490,531 @ $0 · Grant/award (A): 2,731,094 @ $0 · Grant/award (A): 2,470,756 @ $0 | EDGAR |
| 2021-09-13 | 4 | Dudley Robert E. — Chief Executive Officer, Director | Grant/award (A): 4,566 @ $0 | EDGAR |
| 2021-09-13 | 4 | Bourne Steven A. — Chief Administrative Officer | Grant/award (A): 1,305 @ $0 | EDGAR |
| 2021-09-13 | 4 | Hernandez Joseph — Director Blue Water Sponsor LLC | Option exercise (M): 1,437,500 @ $0 · Other (J): 135,000 @ $0 · Option exercise (M): 1,437,500 (derivative) @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1 | EDGAR |
Recent 8-K events — Clarus Therapeutics Holdings, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-01 | 8-K | 1.03 — Bankruptcy or Receivership 2.01 — Completion of Acquisition or Disposition of Assets 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-02-22 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-12-22 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-15 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-06 | 8-K | 1.03 — Bankruptcy or Receivership 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CRXT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs